Compare Aurora Cannabis Inc (ACB) vs Ares Capital Corporation (ARCC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Aurora Cannabis Inc vs Ares Capital Corporation — how do they compare? Aurora Cannabis Inc trades at $2.66 (market cap $165.36M), while Ares Capital Corporation trades at $18.26 (market cap $13.26B). The key difference: Ares Capital Corporation is far larger — about 80.2× Aurora Cannabis Inc's market cap, and Ares Capital Corporation pays a 10.4% dividend while Aurora Cannabis Inc pays none. Which is the better fit depends on your goals.
| ACB | ARCC | |
|---|---|---|
Market Cap | $165.36M | $13.26B |
Sector | Health | Financials |
52-Week High | $6.23 | $23.25 |
52-Week Low | $2.67 | $17.45 |
Enterprise Value | $99.82M | — |
Dividend Yield | — | 10.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.
The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.
ARCC trades at $18.47, down 1.39% on the day, near its consensus low price target of $18.50. The stock shows neutral technical signals with mixed moving averages and oscillators. Recent quarterly EPS results have missed expectations, though the company maintains a high net income margin of 84.5%. A dividend of $0.48 is scheduled for payment on June 30, 2026, supporting income-focused strategies.
Outlook remains cautiously optimistic given strong analyst support (24 Buy, 8 Hold) and a $20.58 consensus target implying ~11% upside. Risks include earnings misses and revenue declines from $1.7B in 2024 to a projected $1.4B in 2026. The stock's P/E of 11.39 and P/B of 0.95 suggest reasonable valuation amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aurora Cannabis Inc
Aurora Cannabis, based in Edmonton, Canada, grows and distributes both medical and recreational cannabis under several brands, including Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. While its main market is Canada, the company has also expanded globally through medical cannabis export agreements.
Read more on ACB →About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →
